Elixir Pharmaceuticals Private Limited
Pharmaceutical company specializing in manufacturing and trading medicines, tinctures, and injections.
2020 | Gurugram, Haryana (India) | Active
Elixir Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 502.01%
- Profit Growth 87.58%
- Ebitda 99.05%
- Net Worth 19.86%
- Total Assets 54.57%
About Elixir Pharmaceuticals
Elixir Pharmaceuticals Private Limited (EPPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 July 2020 (Four years and seven months 2 days old ). Its registered office is in Gurugram, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vishal Agarwal and Prashant Agarwal serve as directors at the Company.
Company Details
- Location
Gurugram, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85100HR2020PTC087947
- Company No.
087947
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jul 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Pharma
Who are the key members and board of directors at Elixir Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishal Agarwal  | Director | 29-Jul-2020 | Current |
| Prashant Agarwal | Director | 29-Jul-2020 | Current |
Financial Performance of Elixir Pharmaceuticals.
Elixir Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 502.01% increase. The company also saw a substantial improvement in profitability, with a 87.58% increase in profit. The company's net worth Soared by an impressive increase of 19.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Elixir Pharmaceuticals?
In 2022, Elixir Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Zodiac Surgical & Medicine Private Limited
Vishal Agarwal and Prashant Agarwal are mutual person
- Luxmisairam Foods Private Limited
Vishal Agarwal and Prashant Agarwal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Elixir Pharmaceuticals?
Elixir Pharmaceuticals has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Elixir Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elixir Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Elixir Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Elixir Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
30 Sep 2024
- Balance Sheet
Elixir Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
31 Mar 2024
- Director Appointment
Vishal Agarwal was appointed as a Director was appointed as a Director on 29 Jul 2020 & has been associated with this company since 4 years 7 months .
29 Jul 2020
- Director Appointment
Prashant Kumar Agarwal was appointed as a Director was appointed as a Director on 29 Jul 2020 & has been associated with this company since 4 years 7 months .
29 Jul 2020
- Company Incorporation
Elixir Pharmaceuticals Private Limited was registered on 29 Jul 2020 with Roc Delhi & aged 4 years 7 months as per MCA records.
29 Jul 2020
Frequently asked questions
What is the Incorporation or founding date of Elixir Pharmaceuticals Private Limited?
Elixir Pharmaceuticals Private Limited was incorporated on 29 Jul 2020.
What is authorized share capital and paid-up capital of Elixir Pharmaceuticals Private Limited?
The authorized share capital of Elixir Pharmaceuticals Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Who are the current board members & directors of Elixir Pharmaceuticals Private Limited?
Currently 2 directors are associated with Elixir Pharmaceuticals Private Limited.
- Vishal Agarwal
- Prashant Kumar Agarwal
What is the registered address of Elixir Pharmaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Elixir Pharmaceuticals Private Limited is C/O Adani Oyster Grande Flat No D-102 Opp. Delhi Public School, Sector-102 India, Gurgaon, Haryana, 122001.
What is the corporate identification number (CIN) and company number of Elixir Pharmaceuticals Private Limited?
The corporate identification number (CIN) of Elixir Pharmaceuticals Private Limited is U85100HR2020PTC087947 and the company number is 087947 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Elixir Pharmaceuticals Private Limited?
According to the financial reports for the fiscal year 2022, the revenue trend for Elixir Pharmaceuticals Private Limited has risen by 502.01%.
What change has been observed in the net worth of Elixir Pharmaceuticals Private Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Elixir Pharmaceuticals Private Limited has experienced an upsurge of 19.86%.
When was the last Balance Sheet of Elixir Pharmaceuticals Private Limited filed with the ROC?
The most recent Balance Sheet for Elixir Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.